Finally, the implication of OX1R, specifically in the rewarding properties of cannabinoids, though not in other pharmacological effects, holds particular interest, as OX1R antagonists might prove beneficial in treating cannabis dependence without interfering with other advantageous properties of cannabinoids in AD [103]. This evidence concerns the gene HCRTR1 and Alzheimer disease.